No Detail Found!

Outcomes of Acromegaly Patients Treated with Sandostatin LAR after Surgical Excision of Pituitary Adenoma

Author(s)
Sumira Kiran Punjab Institute of Neurosciences (PINS), Lahore, Department of Neurosurgery Unit III, Pakistan
Muhammad Kaleem Iftikhar Punjab Institute of Neurosciences (PINS), Lahore, Department of Neurosurgery Unit III, Pakistan
Muhammad Naveed Majeed Punjab Institute of Neurosciences (PINS), Lahore, Department of Neurosurgery Unit III, Pakistan
Ch. Arslan Ahmad Punjab Institute of Neurosciences (PINS), Lahore, Department of Neurosurgery Unit III, Pakistan
Khawar Anwar Punjab Institute of Neurosciences (PINS), Lahore, Department of Neurosurgery Unit III, Pakistan
Asif Bashir Punjab Institute of Neurosciences (PINS), Lahore, Department of Neurosurgery Unit III, Pakistan
Abstract
Materials and Methods: This study was the analysis of a case series of 20 patients (mean age: 30 years) of both genders with acromegaly due to macroadenoma who had endonasal excision and postoperative treatment with Sandostatin LAR. Results: This study consisted of a total of 20 patients out of which 11 (55%) were male and 9 (45%) were female. All 20 Patients (100%) had a headache as their main symptom and 13 patients (65%) had visual field deterioration. 19 patients (95%) had complete resection of the tumor whereas 1 (5%) had a subtotal resection. After surgery and treatment growth hormone levels improved in 19 patients (95%) and remained elevated in 1 patient (5%), IGF-1 (Insulin-like growth factor - 1) levels improved in all 20 (100%) patients. Following consecutive octreotide injections vision of 11 patients (84%) out of 13 improved and in 2 (16%) patients, it remained the same as of Preoperative status whereas Headache improved in all 20 (100%) of the patients. None of the patients had any complications related to the procedure or the injection of octreotide LAR. Conclusion: Acromegaly due to macroadenoma responds well to treatment with octreotide LAR after endonasal resection in terms of hormonal levels and symptoms of the patients. It is a safe treatment with very less side effects and complications.
Publication Details
Page(s) 638-645
Published Journal: Pakistan Journal of Neurological Surgery, Volume: 26, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
Macroadenoma, Growth hormone, Acromegaly, Insulin-like growth factor - 1
0

Citations

0

Downloads

48

Views